Cardiopulmonary Bypass Equipment - Medical Devices Pipeline Assessment, 2020

Cardiopulmonary Bypass Equipment - Medical Devices Pipeline Assessment, 2020

Summary

The publisher's Medical Devices sector report, “Cardiopulmonary Bypass Equipment - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Cardiopulmonary Bypass Equipment pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Cardiopulmonary bypass equipment temporarily takes over the function of heart and lungs during an open heart surgery.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Cardiopulmonary Bypass Equipment under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Cardiopulmonary Bypass Equipment and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment/industry

Reasons to Buy

The report enables you to -

Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with a potentially strong product portfolio and create effective counter-strategies to gain a competitive advantage
Identify and understand important and diverse types of Cardiopulmonary Bypass Equipment under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with a the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date

1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Introduction

2.1 Cardiopulmonary Bypass Equipment Overview

3 Products under Development

3.1 Cardiopulmonary Bypass Equipment - Pipeline Products by Stage of Development
3.2 Cardiopulmonary Bypass Equipment - Pipeline Products by Territory
3.3 Cardiopulmonary Bypass Equipment - Pipeline Products by Regulatory Path
3.4 Cardiopulmonary Bypass Equipment - Pipeline Products by Estimated Approval Date
3.5 Cardiopulmonary Bypass Equipment - Ongoing Clinical Trials

4 Cardiopulmonary Bypass Equipment - Pipeline Products under Development by Companies

4.1 Cardiopulmonary Bypass Equipment Companies - Pipeline Products by Stage of Development
4.2 Cardiopulmonary Bypass Equipment - Pipeline Products by Stage of Development

5 Cardiopulmonary Bypass Equipment Companies and Product Overview6 Cardiopulmonary Bypass Equipment - Recent Developments7 Appendix

List of Tables

Table 1: Cardiopulmonary Bypass Equipment - Pipeline Products by Stage of Development
Table 2: Cardiopulmonary Bypass Equipment - Pipeline Products by Territory
Table 3: Cardiopulmonary Bypass Equipment - Pipeline Products by Regulatory Path
Table 4: Cardiopulmonary Bypass Equipment - Pipeline Products by Estimated Approval Date
Table 5: Cardiopulmonary Bypass Equipment - Ongoing Clinical Trials
Table 6: Cardiopulmonary Bypass Equipment Companies - Pipeline Products by Stage of Development
Table 7: Cardiopulmonary Bypass Equipment - Pipeline Products by Stage of Development
Table 8: AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: AngioVac - Generation 3 - Product Status
Table 10: AngioVac - Generation 3 - Product Description
Table 11: AngioVac - Generation 4 - Product Status
Table 12: AngioVac - Generation 4 - Product Description
Table 13: Circulatory Technology Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 14: Heart Lung Machine - Product Status
Table 15: Heart Lung Machine - Product Description
Table 16: CVD Equipment Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 17: Extracorporeal Membrane Oxygenation Device - Product Status
Table 18: Extracorporeal Membrane Oxygenation Device - Product Description
Table 19: Elsius Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 20: ECMO Portable Device - Product Status
Table 21: ECMO Portable Device - Product Description
Table 22: Ension, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 23: pCAS - Product Status
Table 24: pCAS - Product Description
Table 25: Getinge AB Pipeline Products & Ongoing Clinical Trials Overview
Table 26: Heart-Lung Machine HL 40 - Product Status
Table 27: Heart-Lung Machine HL 40 - Product Description
Table 28: Haemair Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 29: Extracorporeal Membrane Oxygenation (ECMO) Device - Product Status
Table 30: Extracorporeal Membrane Oxygenation (ECMO) Device - Product Description
Table 31: Hemovent GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 32: Mobybox - Product Status
Table 33: Mobybox - Product Description
Table 34: Hemovent GmbH - Ongoing Clinical Trials Overview
Table 35: Mobybox - A Post Market Surveillance Study of the Hemovent Extracorporeal Cardiopulmonary Support System for Cardiac and Respiratory Support: The MOBYBOX Trial
Table 36: LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview
Table 37: LBATS - Product Status
Table 38: LBATS - Product Description
Table 39: New Oxy Apex HP Oxygenator - Product Status
Table 40: New Oxy Apex HP Oxygenator - Product Description

List of Figures

Figure 1: Cardiopulmonary Bypass Equipment - Pipeline Products by Stage of Development
Figure 2: Cardiopulmonary Bypass Equipment - Pipeline Products by Territory
Figure 3: Cardiopulmonary Bypass Equipment - Pipeline Products by Regulatory Path
Figure 4: Cardiopulmonary Bypass Equipment - Pipeline Products by Estimated Approval Date
Figure 5: Cardiopulmonary Bypass Equipment - Ongoing Clinical Trials